GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Nanalysis Scientific Corp (TSXV:NSCI) » Definitions » Capex-to-Operating-Cash-Flow

Nanalysis Scientific (TSXV:NSCI) Capex-to-Operating-Cash-Flow : 0.40 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Nanalysis Scientific Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Nanalysis Scientific's Capital Expenditure for the three months ended in Mar. 2024 was C$-0.58 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2024 was C$1.46 Mil.

Hence, Nanalysis Scientific's Capex-to-Operating-Cash-Flow for the three months ended in Mar. 2024 was 0.40.


Nanalysis Scientific Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Nanalysis Scientific's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanalysis Scientific Capex-to-Operating-Cash-Flow Chart

Nanalysis Scientific Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial 4.02 - - - -

Nanalysis Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.40

Competitive Comparison of Nanalysis Scientific's Capex-to-Operating-Cash-Flow

For the Scientific & Technical Instruments subindustry, Nanalysis Scientific's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanalysis Scientific's Capex-to-Operating-Cash-Flow Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Nanalysis Scientific's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nanalysis Scientific's Capex-to-Operating-Cash-Flow falls into.



Nanalysis Scientific Capex-to-Operating-Cash-Flow Calculation

Nanalysis Scientific's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-4.592) / -11.185
=N/A

Nanalysis Scientific's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-0.578) / 1.464
=0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanalysis Scientific  (TSXV:NSCI) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Nanalysis Scientific Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Nanalysis Scientific's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanalysis Scientific (TSXV:NSCI) Business Description

Traded in Other Exchanges
Address
Bay 1, 4600 5th Street NE, Calgary, AB, CAN, T2E 7C3
Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the a 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. Its operating segments are Nanalysis, RS2D, K'Prime and Corporate. Nanalysis is a patent-protected technology company that develops, manufactures, and sells compact magnetic resonance spectrometers (MR spectrometer) for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. Geographic segments of the group are the U.S., Europe, Canada, Asia and Other regions.
Executives
Michal Okoniewski Director

Nanalysis Scientific (TSXV:NSCI) Headlines

No Headlines